Drug recall · July 5, 2023
Amphotericin B Liposome for Injection recall
Why: Subpotent drug
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Amphotericin B Liposome for Injection, 50mg/vial, Rx only, Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti, Halol-389350, Gujarat, India, NDC 62756-0233-01
- Lots / codes
Lot # BAD0089A, Exp 01/2025; BAD0330A, Exp 07/2025
- Quantity
- 12960 vials
- Company
- Sun Pharmaceutical Industries Inc, Princeton, NJ
- Distribution
- USA nationwide
- Initiated
- May 30, 2023 · N/A
- Classified
- June 29, 2023
- Reported
- July 5, 2023
- Ended
- December 18, 2023
- How notified
- N/A
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amphotericin B
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.